1 Department of Radiology, University Medical Center Regensburg, Franz-Josef-Strauβ-Allee 11, 93053 Regensburg, Germany.
AJR Am J Roentgenol. 2014 Jun;202(6):1215-31. doi: 10.2214/AJR.13.10936.
In patients with acute necrotizing pancreatitis, we analyzed whether laboratory and clinical findings determined in the early phase of disease and morphologic features on contrast-enhanced CT (CECT) at the beginning of the late phase of disease are helpful in predicting patient outcome and whether CECT findings provide additional information in establishing prognosis compared with the laboratory and clinical findings.
A retrospective analysis of 99 patients with acute necrotizing pancreatitis was performed. Four laboratory variables (albumin, calcium, C-reactive protein, WBC count) and three clinical variables (Acute Physiology, Age, Chronic Health Evaluation [APACHE] II score; Simplified Acute Physiology Score [SAPS] II; persistent organ failure) were assessed. Five morphologic features on CECT including Balthazar grade and CT severity index were reviewed. The endpoints of patient outcome were peripancreatic or pancreatic infection, need for intervention, duration of organ failure, ICU and hospital stays, and death. Based on receiver operating characteristic curve analysis for infection, high-and low-risk groups for each prognostic variable were calculated and univariable and multivariable Cox regression analyses were carried out.
In our study population of 99 patients (63 men, 36 women; median age, 52 years; age range, 18-84 years), 25 patients (25%) developed infection, 42 patients (42%) experienced organ failure, and 12 patients (12%) died. Regarding the laboratory and clinical variables, albumin level, APACHE II score, and particularly persistent organ failure were the strongest independent predictors of patient outcome. Regarding the imaging variables, Balthazar grade and a morphologic feature that takes the distribution of intrapancreatic necrosis into account were the strongest independent predictors. In the multivariable analysis of all studied variables, imaging variables were independent and strong predictors of patient outcome and provided additional information in establishing prognosis compared with clinical and laboratory findings.
In patients with suspected or proven acute necrotizing pancreatitis, performing CECT at the beginning of the late phase of disease is recommended to identify patients at increased risk for adverse outcomes.
在急性坏死性胰腺炎患者中,我们分析疾病早期的实验室和临床发现以及疾病晚期开始时的对比增强 CT(CECT)的形态特征是否有助于预测患者的预后,并确定 CECT 发现与实验室和临床发现相比是否提供了预后评估的额外信息。
对 99 例急性坏死性胰腺炎患者进行回顾性分析。评估了 4 项实验室变量(白蛋白、钙、C 反应蛋白、白细胞计数)和 3 项临床变量(急性生理学和慢性健康评估 [APACHE] II 评分;简化急性生理学评分 [SAPS] II;持续器官衰竭)。回顾了 CECT 的 5 种形态特征,包括 Balthazar 分级和 CT 严重程度指数。患者预后的终点是胰周或胰腺感染、需要干预、器官衰竭持续时间、入住 ICU 和住院时间以及死亡。根据感染的受试者工作特征曲线分析,计算了每个预后变量的高风险和低风险组,并进行了单变量和多变量 Cox 回归分析。
在我们的 99 例患者(63 名男性,36 名女性;中位年龄 52 岁;年龄范围 18-84 岁)中,25 例(25%)发生感染,42 例(42%)发生器官衰竭,12 例(12%)死亡。就实验室和临床变量而言,白蛋白水平、APACHE II 评分,特别是持续器官衰竭是患者预后的最强独立预测因素。就影像学变量而言,Balthazar 分级和一种考虑胰内坏死分布的形态特征是最强的独立预测因素。在所有研究变量的多变量分析中,影像学变量是独立的且强有力的预后预测因素,并与临床和实验室发现相比提供了预后评估的额外信息。
对于疑似或确诊的急性坏死性胰腺炎患者,建议在疾病晚期开始时进行 CECT,以识别出预后不良风险增加的患者。